1. What Can Proton Beam Therapy Achieve for Patients with Pectus Excavatum Requiring Left Breast, Axilla and Internal Mammary Nodal Radiotherapy?
- Author
-
Settatree, S., Dunlop, A., Mohajer, J., Brand, D., Mooney, L., Ross, G., Gulliford, S., Harris, E., and Kirby, A.
- Subjects
- *
HEART anatomy , *STATISTICS , *PECTUS excavatum , *CONFIDENCE intervals , *HEART , *AXILLA , *TREATMENT effectiveness , *PROTON therapy , *BREAST , *INTERNAL thoracic artery , *DESCRIPTIVE statistics , *COMPUTED tomography , *DATA analysis , *BREATH holding - Abstract
Exposure of the heart to radiation increases the risk of ischaemic heart disease, proportionate to the mean heart dose (MHD). Radiotherapy techniques including proton beam therapy (PBT) can reduce MHD. The aims of this study were to quantify the MHD reduction achievable by PBT compared with volumetric modulated arc therapy in breath hold (VMAT-BH) in patients with pectus excavatum (PEx), to identify an anatomical metric from a computed tomography scan that might indicate which patients will achieve the greatest MHD reductions from PBT. Sixteen patients with PEx (Haller Index ≥2.7) were identified from radiotherapy planning computed tomography images. Left breast/chest wall, axilla (I–IV) and internal mammary node (IMN) volumes were delineated. VMAT and PBT plans were prepared, all satisfying target coverage constraints. Signed-rank comparisons of techniques were undertaken for the mean dose to the heart, ipsilateral lung and contralateral breast. Spearman's rho correlations were calculated for anatomical metrics against MHD reduction achieved by PBT. The mean MHD for VMAT-BH plans was 4.1 Gy compared with 0.7 Gy for PBT plans. PBT reduced MHD by an average of 3.4 Gy (range 2.8–4.4 Gy) compared with VMAT-BH (P < 0.001). PBT significantly reduced the mean dose to the ipsilateral lung (4.7 Gy, P < 0.001) and contralateral breast (2.7 Gy, P < 0.001). The distance (mm) at the most inferomedial extent of IMN volume (IMN to heart distance) negatively correlated with MHD reduction achieved by PBT (Spearman's rho –0.88 (95% confidence interval –0.96 to –0.67, P < 0.001)). For patients with PEx requiring left-sided breast and IMN radiotherapy, a clinically significant MHD reduction is achievable using PBT, compared with the optimal photon technique (VMAT-BH). This is a patient group in whom PBT could have the greatest benefit. • Pectus excavatum patients requiring left internal mammary nodal photon radiotherapy risk breaching heart dose constraints. • Proton therapy reduces mean heart dose by 3.4 Gy compared with volumetric modulated arc therapy photons in breath hold. • Shorter internal mammary node to heart distance correlates with greater reduction in mean heart dose using protons as compared with photons. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF